Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8859595 Potent and selective inhibitors of hepatitis C virus

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88595950

Patent Inventor Names

Franck Amblard0

Hongwang Zhang0

Junxing Shi0

Longhu Zhou0

Raymond F. Schinazi0

Richard Anthony Whitaker0

Steven J. Coats0

Tamara Rosario McBrayer0

Date of Patent

October 14, 2014

Patent Application Number

138175220

Date Filed

August 26, 2011

Patent Citations Received

‌

US Patent 12084473 β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

‌

US Patent 11707480 Highly active compounds against COVID-19

‌

US Patent 11975016 2′-substituted-N

‌

US Patent 12006340 Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus

Patent Primary Examiner

‌

Samantha Shterengarts

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8859595 Potent and selective inhibitors of hepatitis C virus

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API